KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Debt Ratio (2016 - 2026)

Edwards Lifesciences has reported Debt Ratio over the past 17 years, most recently at 0.04 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 4.59% year-over-year to 0.04; the TTM value through Dec 2025 reached 0.04, down 4.59%, while the annual FY2025 figure was 0.04, 4.59% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.04 at Edwards Lifesciences, down from 0.05 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.08 in Q1 2021 and troughed at 0.04 in Q4 2025.
  • A 5-year average of 0.06 and a median of 0.07 in 2023 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: increased 2.64% in 2022 and later dropped 28.2% in 2024.
  • Year by year, Debt Ratio stood at 0.07 in 2021, then increased by 2.64% to 0.07 in 2022, then dropped by 11.33% to 0.06 in 2023, then dropped by 28.2% to 0.05 in 2024, then decreased by 4.59% to 0.04 in 2025.
  • Business Quant data shows Debt Ratio for EW at 0.04 in Q4 2025, 0.05 in Q3 2025, and 0.04 in Q2 2025.